Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
06/13/1990 | EP0372730A2 N-acetyl glucosamine as a cytoprotective agent |
06/13/1990 | EP0372620A2 Method for the stimulation of bone marrow cells |
06/13/1990 | EP0372541A1 Method for imparting immunosuppression |
06/13/1990 | EP0372523A2 Process of preparing alpha-amylase inhibiting substances from wheat |
06/13/1990 | EP0372522A2 Dieting agents comprising alpha-amylase inhibiting substances from wheat |
06/13/1990 | EP0372410A2 Use of heterocyclic amides to inhibit tumor metastasis |
06/13/1990 | EP0372157A1 Antidiabetic phosphonates |
06/13/1990 | EP0372062A1 Inhibition of lipogenesis |
06/13/1990 | CN1042918A Peptide of effect having bradykinin-antagonistic agent |
06/13/1990 | CN1042917A Stabilization medicines, process for producing them and stabilization pharmaceutical composition |
06/13/1990 | CN1042912A (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
06/12/1990 | US4933369 Analgesics |
06/12/1990 | US4933357 1,3-diazolyl-2-phenylalkyl-2-propanol derivatives |
06/12/1990 | US4933329 Bis-S-alkylbenzene derivatives |
06/12/1990 | US4932934 By injecting prophyrin aggregate, transmitting radiation hydrochloride |
06/12/1990 | CA2004979A1 Production and use of porphyrins |
06/12/1990 | CA1270350A1 Amino thio dipeptides |
06/09/1990 | CA2004886A1 Method for imparting immunosuppression |
06/06/1990 | EP0371921A2 Phenyl aliphatyl amino alkane diphosphonic acids |
06/06/1990 | EP0371733A2 Dopamine-beta-hydroxylase inhibitors |
06/06/1990 | EP0371732A1 Dopamine-beta-hydroxylase inhibitors |
06/06/1990 | EP0371730A1 Dopamine-B-Hydroxylase inhibitors |
06/06/1990 | EP0371594A1 Thiophene-carboxamide derivatives and their pharmaceutical use |
06/06/1990 | EP0371564A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives |
06/06/1990 | EP0371559A2 Use of benzimidazoles in the treatment of epithelial disorders |
06/06/1990 | EP0371495A2 Sialic acid derivative with active ester groups |
06/06/1990 | EP0371438A2 3,5-Di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxiphenyl- 1,2,4-thiadiazoles, -oxadiazoles as antiinflammatory agents |
06/06/1990 | EP0371179A1 Novel analogs of peptidase substrates |
06/06/1990 | EP0371085A1 Dextromethorphan potentiator for anticonvulsant composition and method |
06/06/1990 | CN1042704A Fluoxetine analog |
06/06/1990 | CN1042658A Cytotropic non-homogeneous molecular lipid and its preparation method |
06/06/1990 | CA2004643A1 Indole derivatives, process for their preparation and pharmaceutical compositions containing the same |
06/05/1990 | US4931589 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
06/05/1990 | US4931548 Heterodimer form of transforming growth factor-beta |
06/05/1990 | US4931468 Treating malignant tumors with g-linolenic or dihomo-g-lino-lenic acid or derivatives; combined with zinc, antibiotics |
06/05/1990 | US4931449 2-((4-piperidyl)methyl)benzofuro(2,3-C)pyridine derivatives, and their application in therapy |
06/05/1990 | US4931444 For leukotriene-mediated diseases and disorders |
06/05/1990 | US4931443 Piperazine compound and pharmaceutical use thereof |
06/05/1990 | US4931429 α-aminoacyl β-aminoacyl aminodiols as anti-hypertensive agents |
06/05/1990 | CA1269996A1 Fluorinated diaminoalkyne derivatives |
06/02/1990 | CA2004442A1 Heterocyclic amides to inhibit tumor metastasis |
06/01/1990 | CA2002247A1 Dopamine-.beta.-hydroxylase inhibitors |
06/01/1990 | CA2002246A1 Dopamine-.beta.-hydroxylase inhibitors |
06/01/1990 | CA2002245A1 Dopamine-.beta.-hydroxylase inhibitors |
05/31/1990 | WO1990005755A1 Collagen-polymer conjugates |
05/31/1990 | WO1990005719A1 Hydroxamic acid based collagenase inhibitors |
05/31/1990 | WO1990005716A1 Hydroxamic acid based collagenase inhibitors |
05/31/1990 | WO1990005527A1 Inhibitors for glycosaminosyl transferase-v |
05/31/1990 | WO1990003375A3 Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use |
05/31/1990 | DE3938751A1 New oligopeptide with tetra:hydro:isoquinoline-carboxylic acid residue |
05/30/1990 | EP0370994A2 Treatment of glucose-intermediated cross-linking of collagen in patients with diabetes mellitus by arginin, spermidin, creatin or agmatin |
05/30/1990 | EP0370740A1 Anti-atherosclerotic diaryl compounds |
05/30/1990 | EP0370656A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/30/1990 | EP0370499A2 Use of benzomorphanes in cytoprotection |
05/30/1990 | EP0370453A2 Peptides having a Brady kinine-inhibiting activity |
05/30/1990 | EP0370236A1 Indolocarbazole derivatives, processes for their preparation and their use as medicaments |
05/30/1990 | EP0370220A1 Gestode composition for transdermal application |
05/30/1990 | CN1042545A Application of ethylene amine tetraacetic acid as inhibitor of proteinkinase 2 or proteinkinase c for calcium/calmodulin |
05/30/1990 | CN1042536A Chelants possessing ortho ligating functionality and complexes thereof |
05/29/1990 | US4929754 Benzenesulphonamidoindanyl compounds |
05/29/1990 | US4929736 Inhibitors of elastase, azolides |
05/29/1990 | US4929731 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein |
05/29/1990 | US4929635 New derivatives of 4-vinyl benzoic acid, process for their preparation and their uses in therapeutics and as ligands |
05/29/1990 | US4929626 α-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters and lipoxygenase inhibition therewith |
05/29/1990 | US4929625 Ethers |
05/29/1990 | US4929554 Human immune interferon |
05/29/1990 | US4929549 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors |
05/29/1990 | CA2003984A1 Sialic acid derivative with active ester groups |
05/29/1990 | CA1269668A1 DOPAMINE-.beta.-HYDROXYLASE INHIBITORS |
05/29/1990 | CA1269661A1 Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
05/28/1990 | CA2003766A1 Phenylaliphatylaminoalkanediphosphonic acids |
05/24/1990 | CA2003572A1 Use of benzomorphanes for cytoprotection |
05/23/1990 | EP0369944A1 Substituted oxadiamino butanes |
05/23/1990 | EP0369943A1 Binding protein for insulin-like growth factors |
05/23/1990 | EP0369881A1 Compounds derived from the 3-keto-delta 4,9-19-nor steroid structure, and their use as medicaments |
05/23/1990 | EP0369764A2 Composition for reducing postsurgical adhesions and its use |
05/23/1990 | EP0369685A2 Fluoxetine analog |
05/23/1990 | EP0369463A2 Conjugate of prostaglandin and polysaccharide |
05/23/1990 | EP0369413A2 Interferon-gamma binding proteins |
05/23/1990 | EP0369391A2 N-substituted amides |
05/23/1990 | EP0369279A1 7-oxabicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
05/23/1990 | EP0369278A1 7-oxabicycloheptane imino interphenylene substituted prostaglandin analogs useful in the treatment of thrombotic disease |
05/23/1990 | EP0369263A2 Preparations for the topical treatment of skin diseases |
05/23/1990 | EP0368866A1 Aryl substituted naphthalene, benzoxepine, benzazepine, benzocycloheptene derivatives |
05/23/1990 | EP0221344B1 Sulphonyl-phenyl alkyl amines, process for their preparation and medicines |
05/23/1990 | EP0195084B1 Method of rectification of human leukocytic interferon |
05/23/1990 | CN1042376A Nutritive liquid |
05/23/1990 | CN1042363A 3 beta, 17 beta-hydroxy-substituted steroids and related steroidal compounds |
05/23/1990 | CN1042355A Process for preparing pyrrolidine derivatives and their salts |
05/23/1990 | CN1042347A 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
05/23/1990 | CN1008091B Process for preparation of leukotriene antagonists |
05/23/1990 | CN1008061B Processes for preparing mixture of different dihydropyridines |
05/23/1990 | CA2003719A1 Compounds |
05/22/1990 | US4927975 Antiandrogens, protecting, oxidation, reduction, hydrogenation, halogenation |
05/22/1990 | US4927970 Histamine h2-antagonist, antiulcer |
05/22/1990 | US4927968 Chemical intermediates and process |
05/22/1990 | US4927965 N-(N-succinyl-L-leucyl)agmatine, related compounds and use in pharmacology |
05/22/1990 | US4927959 B-adrenergic blocking agent |
05/22/1990 | US4927944 Enzyme inhibitor |
05/22/1990 | US4927849 Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them |